Reproductive Medicine and Biology, an esteemed journal published by WILEY, stands at the forefront of advancements in the field of reproductive health and associated biological sciences. With an impact factor that underscores its relevance—ranking in Q1 for Reproductive Medicine and Q3 in Cell Biology—this journal is distinguished by its commitment to disseminating high-quality, peer-reviewed research since its transition to Open Access in 2002. Based in Japan, the journal caters to a global audience, providing vital insights into reproductive biology, therapeutics, and innovative practices. With Scopus rankings placing it at #22 out of 90 in Reproductive Medicine and a commendable percentile ranking, Reproductive Medicine and Biology aims to foster dialogue and knowledge transfer among researchers, professionals, and students, paving the way for breakthroughs in understanding reproductive health.

The International Journal of Reproductive Biomedicine, an esteemed publication by SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, serves as a pivotal platform in the fields of obstetrics and gynecology as well as reproductive medicine. Established in 2011 and transitioning to an open access model in 2015, this journal facilitates the dissemination of innovative research and critical findings to a global audience, particularly focusing on advancements in reproductive health and biomedicine. With an impact factor reflective of its commitment to high-quality scientific inquiry, the journal has achieved a notable ranking of Q3 in both its categories for 2023, contributing to its growing influence within the academic community. Researchers and professionals benefit from its broad scope, which encompasses a range of topics essential to reproductive health, thus fostering a rich exchange of knowledge. The journal's accessibility allows students and professionals alike to engage with the latest findings and contribute to ongoing discussions within this vital field of study.

Middle East Fertility Society Journal is a premier open-access publication established in 1996 that caters to the fields of Obstetrics and Gynecology as well as Reproductive Medicine. Published by SPRINGER in Egypt, this journal has made significant strides in disseminating high-quality research and advancements in reproductive health, achieving a 2023 Scopus rank of #102 in Obstetrics and Gynecology and #47 in Reproductive Medicine, placing it in the 51st and 48th percentiles respectively. With an aim to foster collaboration and innovation in the fertility sector, it welcomes researchers and practitioners to share their findings and insights, contributing to the global discourse on reproductive issues. As an open-access journal since 2010, it ensures that the latest research is readily available to a broad audience, enhancing accessibility and knowledge transfer in the vital area of reproductive health.

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

Reproduction and Fertility is a premier academic journal published by BIOSCIENTIFICA LTD, dedicated to advancing knowledge in the fields of reproductive sciences, obstetrics, gynecology, and related areas. Established with a focus on delivering high-quality research, this journal has quickly ascended in prominence, achieving a commendable Q2 ranking in multiple categories, including Embryology, Obstetrics and Gynecology, Reproductive Medicine, and Urology, as of 2023. With an E-ISSN of 2633-8386, Reproduction and Fertility aims to provide a valuable platform for researchers, professionals, and students alike, offering insights into the latest discoveries and innovations in reproductive health. Although currently not an open-access journal, it remains committed to disseminating important findings that can influence clinical practices and policy-making worldwide. Operating from its headquarters in Bristol, United Kingdom, the journal serves as an essential resource for anyone invested in understanding and improving reproductive health outcomes through rigorous academic research.

REPRODUCTION, published by BIOSCIENTIFICA LTD, stands at the forefront of research in the fields of reproductive and developmental biology. With a focus on advancing our understanding of reproductive health and mechanisms, the journal has garnered an impressive reputation, consistently ranking in the first quartile for key categories including Embryology, Endocrinology, Obstetrics and Gynecology, and Reproductive Medicine in 2023. Notably, it holds an esteemed position in the Scopus rankings, with high percentiles that reflect its significant impact in the scientific community. The journal is committed to open access, promoting the broad dissemination of high-quality research to facilitate innovative discoveries and interdisciplinary collaboration. Situated in the United Kingdom, REPRODUCTION serves as a vital resource for researchers, professionals, and students eager to contribute to the evolving landscape of reproductive sciences and related fields.

Asian Pacific Journal of Reproduction is a dynamic open-access journal specializing in a diverse array of topics related to reproduction across various species, including humans, animals, and plants. Published by Wolters Kluwer Medknow Publications, this peer-reviewed journal has been committed to disseminating high-quality research since its inception in 2012. With an accessible ISBN of 2305-0500 and E-ISSN 2305-0519, the journal has rapidly established itself within the academic community, evidenced by its categorization in Q3 and Q4 quartiles across multiple fields, including Obstetrics, Gynecology, and Animal Science. Researchers are encouraged to contribute their findings to foster a deeper understanding of reproductive health and practices in the Asian Pacific region and beyond. The journal's inclusive scope and emphasis on interdisciplinary collaboration make it a crucial platform for professionals and scholars seeking to stay at the forefront of reproductive research.

Human Fertility, published by Taylor & Francis Ltd, is a key academic journal that serves the dynamic fields of medicine, obstetrics and gynecology, and reproductive medicine. Established in 1998 and with converged content extending to 2024, the journal holds a notable Q2 ranking in its respective categories, highlighting its influence and scholarly contributions to current research and practice. With an ISSN of 1464-7273 and an E-ISSN of 1742-8149, it rigorously disseminates studies, reviews, and advancements in human fertility, particularly emphasizing evidence-based practices and innovative techniques. Despite its traditional subscription model, the journal remains vital for researchers, healthcare professionals, and students seeking to foster advancements in reproductive health. Its articles are pivotal in addressing the multifaceted challenges faced in reproductive health and guiding future research trajectories.

Hormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.

Basic and Clinical Andrology, published by BMC, is a leading open access journal dedicated to the advancement of knowledge in the field of reproductive medicine and urology. Since its launch in 2013, the journal has aimed to provide a platform for the dissemination of high-quality research, bridging the gap between basic science and clinical practice. With an impressive reputation evidenced by its Q2 ranking in both reproductive medicine and urology, it serves as a vital resource for researchers, healthcare professionals, and students looking to stay updated on the latest developments in andrology. The journal actively encourages submissions across a diverse range of topics, contributing to our understanding of male reproductive health issues, advancements in treatment protocols, and innovative therapeutic approaches. Located in the United Kingdom, Basic and Clinical Andrology plays a critical role in the global discourse on andrology, offering researchers an opportunity to share their findings with a broad audience committed to improving health outcomes in these crucial fields.